| Trial ID: | L0939 |
| Source ID: | NCT00009009
|
| Associated Drug: |
Immunosuppressive Regimen Designed To Complement Haart
|
| Title: |
Kidney Transplant for HIV-Infected Patients in Renal Failure
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Failure|HIV Infection
|
| Interventions: |
DRUG: immunosuppressive regimen designed to complement HAART
|
| Outcome Measures: |
|
| Sponsor/Collaborators: |
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
10
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT
|
| Start Date: |
2001-01
|
| Completion Date: |
2002-12
|
| Results First Posted: |
|
| Last Update Posted: |
2008-03-04
|
| Locations: |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, Maryland, 20892, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00009009
|
